Condition
Paralympic Athletes
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07056231Not ApplicableCompleted
Effect of Low-Dose Caffeine on Performance in Elite Sitting Volleyball Players
NCT06383286CompletedPrimary
The Relationship Between Physical Activity Levels and Anxiety, Depression, Stress of Disabled Athletes
NCT04748497Not ApplicableUnknownPrimary
Performance Assessement for Paralympic Athletes
Showing all 3 trials